Nanosonics (ASX:NAN) Notes Receivable : A$0.0 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Notes Receivable?

Nanosonics's Notes Receivable for the quarter that ended in Dec. 2024 was A$0.0 Mil.

Nanosonics Notes Receivable Historical Data

The historical data trend for Nanosonics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Notes Receivable Chart

Nanosonics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Notes Receivable

Get a 7-Day Free Trial

Nanosonics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Nanosonics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Nanosonics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Nanosonics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanosonics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

NNCSF:USA OQS:Germany

Address

7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113

Website

https://www.nanosonics.com.au

Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.